Schwarzmüller Group Relies on Fabasoft Approve For Resilient Supply Chain Management
31.3.2021 12:04:00 EEST | Business Wire | Press release
Commercial vehicle manufacturer Schwarzmüller digitalizes its communication with suppliers and adopts paperless order processing. A process-driven portal for managing and controlling data connects Schwarzmüller with its suppliers across the globe.
Fabasoft Approve serves as a central platform for processing orders and communicating with more than 150 suppliers in a seamless, format-independent way. Using a standard interface, all relevant information from the connected ERP (enterprise resource planning) system is integrated into Fabasoft Approve. Automatic notifications from the system ensure that suppliers won’t miss any deadlines or fail to process documents on time. The current status of each individual project can always be viewed in real time, which eliminates an enormous amount of work for the procurement and materials planning departments.
“Manufacturing intelligent vehicles is our core competence. We also focus our innovative strength specifically on ways to simplify and optimize collaboration with our suppliers. End-to-end processes involving supplier communication are critical factors when it comes to making our supply chain more resilient. In this project, Fabasoft showed us just how efficiently digitalization can be implemented ’on time and on budget’ with Fabasoft Approve,” notes Roland Hartwig, CEO of Schwarzmüller Group.
“I am delighted that we were able to contribute our expertise in Schwarzmüller’s digitalization projects. Making technical data and documents available consistently at an early stage means that end-to-end digital supplier integration can be efficiently realized. A win-win situation for everyone involved,” adds Andreas Dangl, Business Unit Executive for Cloud Services at Fabasoft.
Download the case study “A cloud-based supplier portal for resilient supply chain management”
About Fabasoft Approve
Fabasoft Approve is a cloud-based off-the-shelf product for managing technical data and documents in an industrial setting. The standard solution integrates all project partners on a secure, scalable, and highly customizable platform. Creating and editing documents, as well as review, release, and approval processes are achieved efficiently and traceably with significantly less manual effort.
About Schwarzmüller
Schwarzmüller Group is one of Europe's largest full-service providers for utility commercial vehicles. The company develops, produces and services premium vehicles for bespoke added-value transport solutions.
About Fabasoft
Fabasoft is among the leading software product companies and cloud service providers in Europe for digital document management as well as electronic document, process, and records management.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210331005046/en/
Contact information
Fabasoft
Ulrike Kogler
Tel.: +43/732/606162-0
E-mail: ulrike.kogler@fabasoft.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Align Partners Issues Public Shareholder Letter and Submits Formal Shareholder Proposals to DB Insurance9.2.2026 16:26:00 EET | Press release
Align Partners Capital Management Inc. (“Align Partners”), a shareholder of DB Insurance Co., Ltd. (KRX:005830) (“DBI” or the “Company”) holding 1.9%, has issued a public shareholder letter to DBI’s Board of Directors aimed at strengthening capital allocation policy and governance oversight, and submitted formal shareholder proposals for the 2026 Annual General Meeting (“AGM”). Despite DBI’s robust fundamentals—including a 16.1% ROE and a 226% K-ICS ratio—the Company trades at an adjusted PBR of 0.40x, representing a severe 60% discount to its Comprehensive Equity under IFRS17. Align Partners identifies inefficient capital allocation and a lack of independent governance oversight as primary drivers of this persistent undervaluation. The letter notes that DBI’s Return on Required Capital (ROR) of 21.2% significantly lags behind domestic and global peers, reflecting a historical focus on top-line growth over risk-adjusted profitability. This is exacerbated by a passive payout policy and
Promega Unveils Cellular Target Engagement Technology Aimed at Expanding the Druggable Proteome at SLAS 20269.2.2026 14:00:00 EET | Press release
Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate proteins. The TarSeer™ BRETSA™ Target Engagement System is a novel bioluminescence resonance energy transfer-based shift assay for detecting ligand-protein interactions in intact cells using protein denaturation. It gives drug discovery researchers early, target-specific cellular insights by validating weak or early chemical matter and expanding the targets accessible in live-cell drug discovery workflows. The technology will be debuted at the Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition in Boston, February 7-11, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260206015371/en/ “You can now potentially study intracellular target engagement for any protein in live cells,” says M
Eurofins Viracor BioPharma Expands Bioanalytical Capabilities9.2.2026 14:00:00 EET | Press release
Eurofins Viracor BioPharma Services, a long‑standing and trusted partner for clinical trial testing solutions with deep expertise in specialty biomarkers and molecular assays, announces a significant expansion of its service portfolio with the addition of enhanced bioanalytical testing capabilities. These new services are fully aligned with Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), enabling the company to enhance support of biopharmaceutical development programs with greater scientific breadth throughout the drug development workflow. This strategic advancement follows the successful relocation and integration of Eurofins Pharma Bioanalytics Services from St. Charles, Missouri, into Eurofins Viracor BioPharma’s purpose‑built, eleven‑acre facility in Lenexa, Kansas. The bioanalytical organization brings more than two decades of specialized experience in pharmacokinetics, immunogenicity, and biomarker testing. By combining both laboratories’ strengths, Eurofins V
HKTDC to Host World’s Largest One-Stop Jewellery Marketplace9.2.2026 12:37:00 EET | Press release
Organised by the Hong Kong Trade Development Council (HKTDC), the world’s largest one‑stop jewellery marketplace will return in early March under its proven “Two Shows, Two Venues” format. The 12th Hong Kong International Diamond, Gem & Pearl Show will take place from 2 to 6 March at AsiaWorld‑Expo, featuring a wide range of jewellery raw materials. Also, the 42nd Hong Kong International Jewellery Show will be held from 4 to 8 March at the Hong Kong Convention and Exhibition Centre, showcasing finished jewellery pieces. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260207153040/en/ Hong Kong International Jewellery Show and Hong Kong International Diamond, Gem & Pearl Show Jenny Koo, Deputy Executive Director of the HKTDC, said: “This year’s twin jewellery shows bring together some 4,000 exhibitors from over 40 countries and regions, with nearly 70% coming from outside Hong Kong. The HKTDC presents the world’s largest one-s
FlexTrade Integrates CME Group’s FX Spot+ and EBS Market Offerings for Enhanced FX Trading9.2.2026 12:30:00 EET | Press release
FlexTrade Systems(@FlexTrade), a global leader in multi-asset execution and order management systems, today announced an integration with CME Group’s EBS Market central limit order book (CLOB) and its FX Spot+ platform.The move is designed to diversify and deepen the sources of actionable liquidity available to FlexTrade’s FlexFX users through an integration into CME Group's substantial liquidity pools for spots via FX Spot+. Providing firm, anonymous liquidity and no last-look pricing, EBS Market is a venue for both large market participants in search of FX liquidity in an all-to-all CLOB, and for market-making banks hedging FX risk. FX Spot+ further enhances spot liquidity with Futures liquidity from CME Group. This partnership is integral in helping firms further expand FX liquidity and take advantage of global opportunity. Mutual clients of FlexTrade and CME Group can integrate FX Spot+ and EBS Market liquidity into their existing FlexFX workflows, accelerating time to market and r
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom